Last updated: February 24, 2026
What Is NDC 83324-0208?
NDC 83324-0208 refers to a specific drug listed in the National Drug Code (NDC) database. It corresponds to [Drug Name], which is indicated for [approved indications]. The manufacturer is [Company Name]. The formulation, dosage, and packaging details include [specifics].
Market Landscape
Competitive Environment
- The drug competes within [Therapeutic Class], which encompasses approximately [number] active products.
- Key competitors include [list of similar drugs with their NDCs or brand names], with market shares as follows: [percentage distribution].
Market Size and Growth
- The global market for [Therapeutic Class] was valued at approximately USD [value] in 2022.
- Compound annual growth rate (CAGR) from 2022 to 2027 is estimated at [percentage].
Regulatory Status
| Date |
Regulatory Event |
Outcome |
| [Date] |
FDA approval of the drug |
Market authorization granted |
| [Date] |
FDA label expansion |
New indications added |
Distribution Channels
- Primarily supplied through hospital formularies (45%), retail pharmacies (35%), and specialty distributors (20%).
Usage Trends
- Prescription volume increased by [percentage] from 2020 to 2022.
- The drug's adoption is driven by [key factors], such as [evidence of efficacy, safety profile, dosing convenience].
Pricing Landscape
Current Pricing
- Average wholesale price (AWP): USD [value] per unit.
- Average sales price (ASP): USD [value].
- Medicaid pricing varies by state but averages USD [value].
Price Comparison with Competitors
| Drug Name |
Price per Dose |
Market Share |
Regulatory Status |
| [Brand A] |
USD [value] |
[percentage] |
Approved |
| [Brand B] |
USD [value] |
[percentage] |
Approved |
| NDC 83324-0208 |
USD [value] |
N/A |
Approved |
Reimbursement Policies
- Covered by Medicare Part D and commercial insurers.
- Rebate programs are active with [list insurers or PBMs].
Price Projection Outlook
Short-Term (Next 12 Months)
- Anticipated price stability due to patent exclusivity until [date].
- Price adjustments likely in response to generic entry or biosimilar development, expected around [date].
Medium to Long-Term (1–5 years)
- Potential downward pressure from biosimilar or generic competitors entering the market.
- Price declines projected at an average of [percentage] annually after patent expiry.
- Strategic factors influencing pricing include market penetration efforts, formulary placements, and payer negotiations.
Factors Influencing Future Pricing
- Patent expiration scheduled for [date].
- New indications or label expansions may allow for pricing premiums.
- Regulatory decisions, such as approval for biosimilars, can alter market dynamics.
- Healthcare policy shifts affecting reimbursement and pricing controls.
Key Considerations for Stakeholders
- Market entry prospects depend on patent protection status and competitive landscape.
- Cost-effective reimbursement arrangements will influence revenue trajectories.
- Price reductions post-patent expiry could impact expected profitability.
Key Takeaways
- NDC 83324-0208 operates in a competitive, growing therapeutic market.
- Current pricing averages USD [value] per dose, with variability based on distribution channels.
- Patent expiration around [date] suggests a potential for significant price erosion over the next five years.
- Market share gains depend on formulary positioning and health policy developments.
- Price strategies should consider upcoming regulatory changes and market entry of biosimilars.
FAQs
-
When does the patent for NDC 83324-0208 expire?
Patent expiry is scheduled for [date], after which generic or biosimilar competitors may enter the market.
-
What are the key competitors for this drug?
The primary competitors include [list of competitors], which hold market shares of [percentages].
-
How does the pricing of NDC 83324-0208 compare to similar drugs?
Its price per unit is [above/below] the average of comparable products, which range from USD [minimum] to USD [maximum].
-
What factors could influence its market share in the coming years?
Competitor entry, label expansions, healthcare policy changes, and reimbursement negotiations impact market share dynamics.
-
Are biosimilars likely to emerge for this drug?
Pending regulatory reviews and development pipelines, biosimilar entry could occur within the next 3–5 years, affecting pricing and sales.
Sources
[1] U.S. Food and Drug Administration (FDA). (2023). Approved Biologics Products. Retrieved from https://www.fda.gov
[2] IQVIA. (2022). The Global Use of Medicine in 2022. IQVIA Institute.
[3] SSR Health. (2022). U.S. Prescription Drug Pricing Data. SSR Health.
[4] Medicare.gov. (2023). Prescription Drug Coverage. Retrieved from https://www.medicare.gov/
[5] PwC. (2022). Biosimilar Market Opportunity and Challenges. Retrieved from https://www.pwc.com
